SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-018985
Filing Date
2020-04-28
Accepted
2020-04-28 07:15:16
Documents
3
Period of Report
2020-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clsd-8k_20200427.htm 8-K 45523
2 EX-99.1 clsd-ex991_6.htm EX-99.1 20122
3 GRAPHIC gu5txurigzjr000001.jpg GRAPHIC 2751
  Complete submission text file 0001564590-20-018985.txt   70878
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 20822290
SIC: 2834 Pharmaceutical Preparations